Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of <scp>STAT3</scp> ‐mediated cancer development-Reference-Cited by-同舟云学术

Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3 ‐mediated cancer development

Published:2022-09-25 Issue:11 Volume:6 Page:3234-3246
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Seo Eun‐Bi¹²,Jang Hyun‐Jun³,Kwon Sun‐Ho¹,Kwon Yong‐Jin¹²,Kim Seul‐Ki¹,Lee Song‐Hee¹,Jeong Ae Jin¹,Shin Hyun Mu⁴,Kim Yong‐Nyun⁵,Ma Stephanie⁶^ORCID,Kim Haeryoung⁷,Lee Yun‐Han⁸,Suh Pann‐Ghill³⁹,Ye Sang‐Kyu¹²⁴¹⁰¹¹

Affiliation:

1. Department of Pharmacology and Biomedical Sciences Seoul National University College of Medicine Seoul Republic of Korea

2. Biomedical Science Project (BK21PLUS) Seoul National University College of Medicine Seoul Republic of Korea

3. School of Life Sciences Ulsan National Institute of Science and Technology Ulsan Republic of Korea

4. Wide River Institute of Immunology Seoul National University Hongcheon Republic of Korea

5. Division of Translational Science National Cancer Center Goyang Republic of Korea

6. State Key Laboratory of Liver Research Li Ka Shing Faculty of Medicine, The University of Hong Kong Hong Kong

7. Department of Pathology Seoul National University College of Medicine Seoul Republic of Korea

8. Department of Molecular Medicine Keimyung University School of Medicine Daegu Republic of Korea

9. Korea Brain Research Institute (KBRI) Daegu Republic of Korea

10. Ischemic/Hypoxic Disease Institute Seoul National University College of Medicine Seoul Republic of Korea

11. Neuro‐Immune Information Storage Network Research Center Seoul National University College of Medicine Seoul Republic of Korea

Funder

Korea Forest Service

National Research Foundation of Korea

Rural Development Administration

Seoul National University Hospital

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.2077

Reference45 articles.

1. Hepatocellular Carcinoma

2. Cancer statistics, 2019

3. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

4. Hepato‐cellular carcinoma;Gilsanz GV;Ann Gastroenterol Hepatol (Paris),1989

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological anti-tumor effects of natural Chamaecyparis obtusa (siebold & zucc.) endl. Leaf extracts on breast cancer;Journal of Ethnopharmacology;2023-09

2. Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma;Journal of Cellular and Molecular Medicine;2023-03-15

3. Role of phospholipases in hepatocellular carcinoma;Phospholipases in Physiology and Pathology;2023